leisure time -WSS

leisure time

author：leisure time 2025-09-29 01:37:00 - browse：45131

Nick Leschly - Bluebird Bio — Longtime Bluebird Bio CEO Nick Leschly Wendy Maeda/The Boston Globe

Some two years after splitting biotech company Bluebird Bio into two entities in a bid to “sharpen their focus” and improve operations, the spinout focused on oncology treatments announced major cost cuts and is parting ways with its chief executive.

The spinout, 2Seventy Bio, announced Tuesday that it is cutting approximately 40% of its workforce, or about 176 employees. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The cuts extend the company’s cash runway into 2026.

The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle. The company was wrestling with its gene therapy portfolio, including getting approval for a gene therapy for the blood disorder beta thalassemia in the U.S. Separately, it had a basket of cancer drug candidates and a partnership with pharma company Bristol Myers Squibb that needed attention. So, Bluebird split its operations in two, with longtime CEO Nick Leschly taking the helm at the new firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： A new House health package & hospitals’ new site

WSS

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Beyond aggravation: Constipation is an American epidemic

Guardant Health colon cancer test endorsed by FDA advisory panel

Some medical students still think black patients feel less pain

AstraZeneca chief proposes a novel edit to the drug pricing bill

Humana sues Biden admin over Medicare Advantage audit rule

explore

leisure time

focus

Virginia high school admissions case could be legal follow

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Supreme Court strikes down use of affirmative action

AstraZeneca chief proposes a novel edit to the drug pricing bill

Affirmative action in medical school literally saved lives

Louisiana bill approved classifying abortion pills as controlled substances

Jerome Adams on the need for new antivirals for Covid

A new House health package & hospitals’ new site

Virginia high school admissions case could be legal follow

Amazon on where the company's health care bets are headed next

focus

AstraZeneca chief proposes a novel edit to the drug pricing bill

How generative AI is inspiring dreams of a health data revolution

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

J&J reports mixed data on next

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

knowledge

knowledge

explore

focus